Paperpal Prime Logo

Contrast Media and Molecular Imaging : Impact Factor & More

eISSN: 1555-4317pISSN: 1555-4309

Key Metrics

CiteScore
4.9
H-Index
58
SJR
Q3Medicine (miscellaneous)
SNIP
0.99
Recommended pre-submission checks
Powered by Paperpal by Editage

Contrast Media and Molecular Imaging Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • SJR SJR
Overview
Publisher Hindawi

Planning to publish in Contrast Media and Molecular Imaging ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Contrast Media and Molecular Imaging

RETRACTION: Clinical Value Study on Contrast-Enhanced Ultrasound Combined with Enhanced CT in Early Diagnosis of Primary Hepatic Carcinoma.
  • 1 Jan 2026
  • Contrast media & molecular imaging
Correction to “Prostate Osteoblast‐Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients”
  • 30 Dec 2025
  • Contrast Media & Molecular Imaging
RETRACTION: The Clinical Noteworthiness of Plasma NT-ProBNP Standard in Sufferers with Cardiogenic Cerebral Embolism and Its Diagnostic Value for Such Sufferers
  • 23 Sep 2025
  • Contrast Media & Molecular Imaging
RETRACTION: COVID-19 Semantic Pneumonia Segmentation and Classification Using Artificial Intelligence
  • 22 Sep 2025
  • Contrast Media & Molecular Imaging
RETRACTION: Image Features of Resting-State Functional Magnetic Resonance Imaging in Evaluating Poor Emotion and Sleep Quality in Patients with Chronic Pain under Artificial Intelligence Algorithm
  • 1 Jan 2025
  • Contrast Media & Molecular Imaging
RETRACTION: The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer
  • 1 Jan 2025
  • Contrast Media & Molecular Imaging
RETRACTION: Clinical Value Study on Contrast-Enhanced Ultrasound Combined with Enhanced CT in Early Diagnosis of Primary Hepatic Carcinoma.
  • 1 Jan 2026
  • Contrast media & molecular imaging
Correction to “Prostate Osteoblast‐Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients”
  • 30 Dec 2025
  • Contrast Media & Molecular Imaging
RETRACTION: The Clinical Noteworthiness of Plasma NT-ProBNP Standard in Sufferers with Cardiogenic Cerebral Embolism and Its Diagnostic Value for Such Sufferers
  • 23 Sep 2025
  • Contrast Media & Molecular Imaging
RETRACTION: COVID-19 Semantic Pneumonia Segmentation and Classification Using Artificial Intelligence
  • 22 Sep 2025
  • Contrast Media & Molecular Imaging
RETRACTION: Image Features of Resting-State Functional Magnetic Resonance Imaging in Evaluating Poor Emotion and Sleep Quality in Patients with Chronic Pain under Artificial Intelligence Algorithm
  • 1 Jan 2025
  • Contrast Media & Molecular Imaging
RETRACTION: The Significance of PAX8-PPARγ Expression in Thyroid Cancer and the Application of a PAX8-PPARγ-Targeted Ultrasound Contrast Agent in the Early Diagnosis of Thyroid Cancer
  • 1 Jan 2025
  • Contrast Media & Molecular Imaging

FAQs on Contrast Media and Molecular Imaging